Clin Chem Lab Med. 2026 Jul 22. doi: 10.1515/cclm-2026-1026. Online ahead of print. NO ABSTRACT PMID:42478225 | DOI:10.1515/cclm-2026-1026
Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): Zhifang Yao, Ping Yang, Xiang Qian
Clin Chem Lab Med. 2026 Jul 21. doi: 10.1515/cclm-2026-0380. Online ahead of print. ABSTRACT INTRODUCTION: The identification of early biomarkers is a critical prerequisite for the development and optimization of preventive strategies targeting preterm prelabour rupture of membranes (pPROM). The aim of this systematic review was to evaluate first trimester serum biomarkers for predicting the … Read more
Publication date: October 2026 Source: Clinical Biochemistry, Volume 145 Author(s): Alberto Izquierdo-Martínez, Jose Luis Rubio-Prieto, Ana Rodriguez-Rodriguez, Zoraima Martínez-Martos, Carmen Delgado-Pecellín
Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): Zeynep Şule Evren, Kamil Taha Uçar
Clin Chem. 2026 Jul 17:hvag085. doi: 10.1093/clinchem/hvag085. Online ahead of print. NO ABSTRACT PMID:42467676 | DOI:10.1093/clinchem/hvag085
Clin Chem. 2026 Jul 17:hvag082. doi: 10.1093/clinchem/hvag082. Online ahead of print. ABSTRACT BACKGROUND: Cardiac myosin binding protein C (cMyC) is a cardiac-specific biomarker that is released after acute ischemic myocardial injury. Cardiac troponins are established cardiac biomarkers of myocardial injury and provide prognostic information in patients with cardiovascular disease (CVD) and in healthy persons from … Read more
Publication date: October 2026 Source: Clinical Biochemistry, Volume 145 Author(s): Jillian Kodger, Joe M. El-Khoury
Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): Yiming Jia, Lulu Sun, Mengyao Shi, Daoxia Guo, Yanbo Peng, Tan Xu, Yonghong Zhang, Zhengbao Zhu
Clin Chem Lab Med. 2026 Jul 17. doi: 10.1515/cclm-2026-0201. Online ahead of print. ABSTRACT OBJECTIVES: Practical implementation of patient-based real-time quality control (PBRTQC) requires analyte- and institution-specific optimization. This study evaluated the operational feasibility of average-of-normals (AoN)-based PBRTQC through a structured selection process and prospective event-based validation. METHODS: PBRTQC monitoring was performed using the Average … Read more
